Welcome to Skin cancer and Mesothelioma Cancer

Mesothelioma Cancer, Melanoma Cancer, Mesothelioma, Mesothelioma Lawyer
==================================================================

Sunday, February 24, 2008

Fwd: Georgia Capitol Notes



---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Sat, Feb 16, 2008 at 7:08 PM
Subject: Georgia Capitol Notes
To: mesothelioma77@gmail.com


HEADLINES Georgia Republicans' long-promised war on property taxes got underway at the state Capitol.

Sat, 16 Feb 2008 23:16:04 GMT


Source: http://www.macon.com/220/story/269669.html
--
 Powered by RssFwd, a service of Blue Sky Factory, Inc


Fwd: EnPro Industries Turns To Profit In Q4 [NPO]



---------- Forwarded message ----------
From: Live Search News: asbestos cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: EnPro Industries Turns To Profit In Q4 [NPO]
To: mesothelioma77@gmail.com


RTT News - ... quarter results, posting a turn in to a profit from loss in the year ago quarter, helped by a one-time gain and lower asbestos ... trial, CB7630 was administered orally, once daily, to chemotherapy-naïve patients with castration resistant prostate cancer ...

Thu, 14 Feb 2008 20:13:00 GMT

___
Source: http://www.rttnews.com/sp/breakingnews.asp?date=02/14/2008&item=153
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 

Fwd: Vic anti-smoking groups lobbying for ban extension



---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:07 PM
Subject: Vic anti-smoking groups lobbying for ban extension
To: mesothelioma77@gmail.com


Anti-smoking groups say the new laws are working, and should be tightened even further There has been a victory in the battle against smoking, with new figures showing that young people are butting out in ...

Fri, 15 Feb 2008 03:57:03 GMT


Source: http://www.abc.net.au/news/stories/2008/02/15/2163840.htm
--
 Powered by RssFwd, a service of Blue Sky Factory, Inc


Fwd: Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI.



---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:07 PM
Subject: Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRI.
To: mesothelioma77@gmail.com


[1]Eur Radiol. 2008 Feb 13;
Veltman J, Mann R, Kok T, Obdeijn IM, Hoogerbrugge N, Blickman JG, Boetes C

The appearance of malignant lesions in BRCA1 and BRCA2 mutation carriers (BRCA-MCs) on mammography and magnetic resonance imaging (MRI) was evaluated. Thus, 29 BRCA-MCs with breast cancer were retrospectively evaluated and the results compared with an age, tumor size and tumor type matched control group of 29 sporadic breast cancer cases. Detection rates on both modalities were evaluated. Tumors were analyzed on morphology, density (mammography), enhancement pattern and kinetics (MRI). Overall detection was significantly better with MRI than with mammography (55/58 vs 44/57, P = 0.021). On mammography, lesions in the BRCA-MC group were significantly more described as rounded (12//19 vs 3/13, P = 0.036) and with sharp margins (9/19 vs 1/13, P = 0.024). On MRI lesions in the BRCA-MC group were significantly more described as rounded (16/27 vs 7/28, P = 0.010), with sharp margins (20/27 vs 7/28, P

___
Source: http://www.hubmed.org/display.cgi?uids=18270717
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Oncogenic K-ras promotes early carcinogenesis in the mouse proximal colon.
To: mesothelioma77@gmail.com


[1]Int J Cancer. 2008 Feb 12;
Calcagno SR, Li S, Colon M, Kreinest PA, Thompson EA, Fields AP, Murray NR

Oncogenic K-ras mutations are frequently observed in colon cancers and contribute to transformed growth. Oncogenic K-ras is detected in aberrant crypt foci (ACF), precancerous colonic lesions, demonstrating that acquisition of a K-ras mutation is an early event in colon carcinogenesis. Here, we investigate the role of oncogenic K-ras in neoplastic initiation and progression. Transgenic mice in which an oncogenic K-ras(G12D) allele is activated in the colonic epithelium by sporadic recombination (K-rasLA2 mice) develop spontaneous ACF that are morphologically indistinguishable from those induced by the colon carcinogen azoxymethane (AOM). Similar neoplastic changes involving the entire colon are induced in transgenic mice constitutively expressing K-ras(G12D) throughout the colon (LSL-K-ras(G12D)/Villin-Cre mice). However, the biochemistry and fate of K-ras-induced lesions differ depending upon their location within the colon in these mice. In the proximal colon, K-ras(G12D) induces increased expression of procarcinogenic protein kinase CbetaII (PKCbetaII), activation of the MEK/ERK signaling axis and increased epithelial cell proliferation. In contrast, in the distal colon, K-ras(G12D) inhibits expression of procarcinogenic PKCbetaII and induces apoptosis. Treatment of K-rasLA2 mice with AOM leads to neoplastic progression of small ACF to large, dysplastic microadenomas in the proximal, but not the distal colon. Thus, oncogenic K-ras functions differently in the proximal and distal colon of mice, inducing ACF capable of neoplastic progression in the proximal colon, and ACF with little or no potential for progression in the distal colon. Our data indicate that acquisition of a K-ras mutation is an initiating neoplastic event in proximal colon cancer development in mice. (c) 2008 Wiley-Liss, Inc.



___
Source: http://www.hubmed.org/display.cgi?uids=18271008
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Chemical regulation of epigenetic modifications: Opportunities for new cancer therapy.
To: mesothelioma77@gmail.com


[1]Med Res Rev. 2008 Feb 12;
Zheng YG, Wu J, Chen Z, Goodman M

Epigenetics is concerned about heritable changes in gene expression without alteration of the coding sequence. Epigenetic modification of chromatin includes methylation of genomic DNA as well as post-translational modification of chromatin-associated proteins, in particular, histones. The spectrum of histone and non-histone modifications ranges from the addition of relatively small groups such as methyl, acetyl and phosphoryl groups to the attachment of larger moieties such as poly(ADP-ribose) and small proteins ubiquitin or small ubiquitin-like modifier (SUMO). The combinatorial nature of DNA methylation and histone modifications constitutes a significant pathway of epigenetic regulation and considerably extends the information potential of the genetic code. Chromatin modification has emerged as a new fundamental mechanism for gene transcriptional activity control associated with many cellular processes like proliferation, growth, and differentiation. Also it is increasingly recognized that epigenetic modifications constitute important regulatory mechanisms for the pathogenesis of malignant transformations. We review here the recent progress in the development of chemical inhibitors/activators that target different chromatin modifying enzymes. Such potent natural or synthetic modulators can be utilized to establish the quantitative contributions of epigenetic modifications in DNA regulated pathways including transcription, replication, recombination and repair, as well as provide leads for developing new cancer therapeutics. (c) 2008 Wiley Periodicals, Inc. Med Res Rev.



___
Source: http://www.hubmed.org/display.cgi?uids=18271058
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs.



---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Preclinical efficacy on GSK-3 inhibitors: Towards a future generation of powerful drugs.
To: mesothelioma77@gmail.com


[1]Med Res Rev. 2008 Feb 12;
Martinez A

The renewed interest in glycogen synthase kinase-3 (GSK-3), involved in the molecular pathogenesis of human severe diseases, is focused on the potential of its inhibitors to treat diseases that have significant limitations in their current treatments. During the last 5 years, a lot of literature discuss progress in the search and pharmacological actions of GSK-3 inhibitors, but now, evidence have been accumulated showing preclinical efficacy for these new drugs, in very different models of several distinct pathologies. These studies have been summarized in the present review offering promising examples for new therapies for diabetes, cancer, inflammation, Alzheimer's disease and other neurological pathologies, and mood disorders. Now, clinical human trials are awaiting to confirm the ray of hope that GSK-3 inhibitors are arising for the future treatment of severe unmet diseases. (c) 2008 Wiley Periodicals, Inc. Med Res Rev.



___
Source: http://www.hubmed.org/display.cgi?uids=18271054
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Radiology Degree Online - Sponsored Link



---------- Forwarded message ----------
From: Moreover Technologies - Top stories - of 854 returned <rssfwd@rssfwd.com>
Date: Fri, Feb 22, 2008 at 9:08 AM
Subject: Radiology Degree Online - Sponsored Link
To: collegeschoolloan@gmail.com


Ad - Explore degree options in Radiology/X-ray. Free online school info!

Fri, 22 Feb 2008 12:28:00 GMT

___
Source: http://context4.kanoodle.com/cgi-bin/rss_query_image.cgi?a=click&bid_id=90179244&clickid=87877635&format=xml1&cgroup=topstories&query=general%20network&ts=ad20080222120000
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc

 

Fwd: Anxiety Disorders, National Mental Health Information Center



 



---------- Forwarded message ----------
From: CounsellingResource.com Search: mesothelioma diagnosis <rssfwd@rssfwd.com>
Date: Thu, Feb 21, 2008 at 5:06 PM
Subject: Anxiety Disorders, National Mental Health Information Center
To: collegeschoolloan@gmail.com


...Health Information Center. Contents What are anxiety disorders? Generalized Anxiety Disorder symptoms diagnosis treatment Panic Disorder symptoms diagnosis treatment Phobias symptoms diagnosis treatment Post-traumatic Stress...



___
Source: http://counsellingresource.com/distress/anxiety-disorders/anxiety-nmhic.html
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc